|
| 35241644 | An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion. | Nat Commun | 2022 |
| 35947423 | Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study. | JMIR Res Protoc | 2022 |
| 34025472 | A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression. | Front Psychiatry | 2021 |
| 28044255 | Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study. | Adv Ther | 2017 |
| 27253658 | Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. | J Clin Psychopharmacol | 2016 |
| 25349168 | ADAR2-dependent GluA2 editing regulates cocaine seeking. | Mol Psychiatry | 2015 |
| 26240742 | A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone. | Ther Adv Drug Saf | 2015 |
| 24105466 | MeCP2: a novel Huntingtin interactor. | Hum Mol Genet | 2014 |
| 23288715 | Feasibility and impact on surgical outcomes of modified double-stapling technique for patients undergoing laparoscopic anterior resection. | J Gastrointest Surg | 2013 |
| 25062675 | Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease. | J Huntingtons Dis | 2013 |
| 22043863 | Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. | J Neurochem | 2012 |
| 22848491 | Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. | PLoS One | 2012 |
| 21496570 | Molecular biology of Huntington's disease. | Handb Clin Neurol | 2011 |
| 19850138 | Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". | Neuroimage | 2010 |
| 20810894 | Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. | J Neurosci | 2010 |
| 20613636 | Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease. | J Neuropathol Exp Neurol | 2010 |
| 18818671 | Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain. | Gene Ther | 2009 |
| 18400894 | Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. | J Neurosci | 2008 |
| 18923047 | Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. | J Neurosci | 2008 |
| 18931668 | Linking SNPs to CAG repeat length in Huntington's disease patients. | Nat Methods | 2008 |
| 18945913 | Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. | J Neurosci | 2008 |
| 18608091 | 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. | Amyotroph Lateral Scler | 2008 |
| 18278040 | CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. | Nat Neurosci | 2008 |
| 17519223 | Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. | Hum Mol Genet | 2007 |
| 17544587 | Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease. | Neuroscience | 2007 |
| 17550429 | Dopamine release is impaired in a mouse model of DYT1 dystonia. | J Neurochem | 2007 |
| 17376435 | Finding diamonds in the rubble. | Exp Neurol | 2007 |
| 17409194 | Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. | Hum Mol Genet | 2007 |
| 17467140 | Transcriptional signatures in Huntington's disease. | Prog Neurobiol | 2007 |
| 16595660 | Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. | J Biol Chem | 2006 |
| 17017871 | Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death). | Curr Alzheimer Res | 2006 |
| 17192438 | Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. | J Neurosci | 2006 |
| 17182994 | Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness. | N Engl J Med | 2006 |
| 16820007 | Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse. | Eur J Neurosci | 2006 |
| 16932577 | Mechanisms of disease: Histone modifications in Huntington's disease. | Nat Clin Pract Neurol | 2006 |
| 16914060 | Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. | BMC Med Genet | 2006 |
| 16442295 | Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. | Neurobiol Dis | 2006 |
| 16183657 | Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. | Hum Mol Genet | 2005 |
| 14993615 | Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. | Proc Natl Acad Sci U S A | 2004 |
| 15717013 | The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration. | NeuroRx | 2004 |
| 15201461 | Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain. | Methods Mol Biol | 2004 |
| 15201460 | Neurotransmitter receptor analysis in transgenic mouse models. | Methods Mol Biol | 2004 |
| 12498958 | Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. | Neurobiol Aging | 2003 |
| 12900792 | A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. | Am J Hum Genet | 2003 |
| 14678777 | Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. | Neurobiol Dis | 2003 |
| 14597227 | Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology. | Brain Res Mol Brain Res | 2003 |
| 12593136 | Diffusion-weighted magnetic resonance imaging abnormalities in Bartonella encephalopathy. | J Neuroimaging | 2003 |
| 12799135 | Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation. | Mol Cell Neurosci | 2003 |
| 12165556 | Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. | Hum Mol Genet | 2002 |
| 12354289 | Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease. | J Neurochem | 2002 |